Michael Polansky: Pioneering AI Innovations with Living Human Tissue

In a world often dominated by towering egos, Michael Polansky stands out for his humility and intellect. At a charming café in Mill Valley, California, this unassuming entrepreneur is making waves in the intersection of artificial intelligence and biology. As the founder of Outer Biosciences, Polansky has embarked on a groundbreaking mission: to keep living human skin alive outside the body for extended periods, a feat that could revolutionize medical research.

Polansky's journey began in Minnesota, where he grew up before heading to Harvard to study applied mathematics and computer science, graduating in 2006. His professional path took him to Bridgewater Associates, a hedge fund known for its unique culture. However, after three years, he sought a new challenge in the dynamic environment of Silicon Valley, which soon led him to a serendipitous introduction to Sean Parker at a wedding. This connection opened the door to a role at Founders Fund, where he thrived alongside industry pioneers.

After a successful stint with Parker, who later wanted to establish his family office, Polansky transitioned into managing Parker's diverse business and philanthropic interests, including the Parker Institute for Cancer Immunotherapy. However, a significant shift occurred in his life when he met Stefani Germanotta, famously known as Lady Gaga, through her mother, Cynthia Germanotta, at a birthday celebration in late 2019. Their relationship blossomed into a genuine partnership, blending both personal and professional elements.

Polansky's relationship with Gaga has been multifaceted, particularly as they worked together on her Haus Labs cosmetics brand and managed her recent world tour, likening the logistics to running a large startup on the move. Beyond the celebrity lifestyle, Polansky's primary focus remains on Outer Biosciences, a company he founded in 2022, which aims to address the slow pace of innovation in biological research.

Outer Biosciences takes an innovative approach by sourcing human skin from discarded surgical materials—primarily from plastic surgeries—through ethical channels that ensure donor consent and oversight. This living tissue can be maintained for up to a month, far exceeding the typical viability period of just a few days, allowing researchers to observe biological processes over time.

This extended lifespan enables the study of slower biological reactions, such as collagen remodeling and pigmentation changes, which traditional methods fail to capture. Polansky emphasizes that their proprietary system nourishes the tissue while removing metabolic waste, preserving its original molecular architecture. He explains that this capability allows researchers to induce conditions like UV damage and meticulously monitor the skin's subsequent responses over weeks.

The venture has drawn interest not only for its scientific potential but also for the ethical frameworks supporting it. Polansky clarifies that all tissue samples received are de-identified, ensuring donor privacy while allowing for a diverse pool of samples to enhance research. Outer Biosciences' strategy is not just about the technology itself but how it integrates various elements to advance biological understanding.

As Polansky reflects on his journey from finance to life sciences, he acknowledges the unexpected nature of his current path. Yet, his dual life—managing a cutting-edge biotech company while nurturing a relationship with one of the world's most famous entertainers—highlights a unique blend of ambition and authenticity.

Source: techcrunch.com